• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX SA VIDAS® RUB IGG II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX SA VIDAS® RUB IGG II Back to Search Results
Catalog Number 30221
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
A customer in italy notified biomérieux of obtaining non reproducible results when testing a patient's samples using vidas rub igg ii 60 tests (ref.30221, batch 1008940030, expiry date 01-sep-2022) on their vidas 3 (serial number vn03643) compared to another batch.Patient sample id (b)(6): positive result on 22-dec-2021 using vidas rub igg ii 60 tests batch 1008851780 : 17 iu/ml.The patient¿s history showed numerous negative results for anti-rubella igg since (b)(6) 2021.Equivocal result from retest of the same sample on (b)(6) 2021 using vidas rub igg ii 60 tests batch 1008940030: 10 iu/ml and 12 iu/ml.The anti-rubella virus igm tested negative for this sample.Patient sample id (b)(6) sample received in (b)(6) 2020, stored frozen: negative result obtained on (b)(6) 2021 using vidas rub igg ii 60 tests batch 1008940030: 0 iu/ml.It is to be noted that these results were preceded by a valid calibration on (b)(6) 2021 and on (b)(6) 2021 for batch 1008851780 and on (b)(6) 2021 for batch 1008940030.No further information about patient¿s clinical context were available.It was reported that there was no patient harm.Patient results were not affected, nor was there any delay in reporting them.No wrong result was communicated to the physician.
 
Manufacturer Narrative
An internal investigation was performed.Investigation results.Device history record.There was no capa nor any non-conformity on vidas rub igg ii (ref.30221) linked with customer¿s complaint.Complaint analysis.Up to now, no other complaint for a similar issue was recorded on vidas rub igg ii (ref.30221) lot 1008940030.Test/analysis performed.No customer sample was returned and therefore no sample was available for investigation.Control charts analysis.The complaints laboratory analyzed the results of five internal samples (targets 17.9 - 11.5 -15.3 ¿ 7.32 and 4.79 ui/ml) using six different lots including vidas rub igg ii (ref.30221) lots 1008851780 and 1008940030 mentioned by the customer.The analysis of the control charts showed that all results are within specifications.Customer¿s lot is in the trend of the other lots.Tests performed by complaint laboratory.The complaint laboratory tested four internal samples (targets 17.9 - 11.5 -15.3 and 7.32 ui/ml) using retain kits of vidas rub igg ii (ref.30221) customer¿s lot 1008851780 and lot 1008940030.All the results obtained were within specifications, and similar between the two lots.No significant difference of activity was observed between the two lots compared to those observed before the batch release.Support instrument analysis.Support instrument analysis checked the ml2 logs.No instrument issue was detected.Root cause analysis and conclusion.The complaints laboratory did not reproduce the issue observed by the customer when testing internal samples.The complaints laboratory performed tests on four internal samples, using retain kits of vidas rub igg ii (ref.30221) lots 1008851780 and 1008940030.All sample results were within their expected specifications and similar between the two lots.There was no drift of the customer¿s lot since its release.The root cause has not been identified.Without customer¿s returned samples, the investigation could not be further pursued.According to the investigation above, vidas rub igg ii lots 1008851780 and 1008940030 are still within their expected performances.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® RUB IGG II
Type of Device
VIDAS® RUB IGG II
Manufacturer (Section D)
BIOMÉRIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR  69280
Manufacturer (Section G)
BIOMÉRIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR   69280
Manufacturer Contact
dima amro
5 rue des aqueducs
craponne 69290
FR   69290
MDR Report Key13371393
MDR Text Key294501320
Report Number8020790-2022-00019
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2022
Device Catalogue Number30221
Device Lot Number1008940030
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/29/2021
Initial Date FDA Received01/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-